Innovative Disruption in the World of Neuromuscular Blockade: What Is the “State of the Art?”

    loading  Checking for direct PDF access through Ovid

Abstract

(Abstracted from Anesthesiology, 126:12–15, 2017)

This editorial provides an overview of why sugammadex should be preferred for the reversal of neuromuscular block, especially now that it has US Food and Drug Administration approval, as well as highlighting the need for neuromuscular blockade monitoring.

Related Topics

    loading  Loading Related Articles